31 Mar 2021
Assets317.21
Total Income248.86
Profit After Tax21.09
NET Worth132.68
Reserves and Surplus75.96
Total Borrowing122.93
Open 22nd Feb 2024 · Close 26th Feb 2024 · Listing 29th Feb 2024
The shares listed at ₹215.00, a 15.59% move from the issue price. GPT Healthcare is a Mainboard IPO with an issue size of ₹525.14 crore, proposed for listing on BSE, NSE. The offer opens on 22nd Feb 2024 and closes on 26th Feb 2024. The issue structure includes a fresh issue of ₹40.00 crore and an offer-for-sale component of ₹485.14 crore. The current listing schedule points to 29th Feb 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 80 | ₹14,880 |
| Object | Amount |
|---|---|
| Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company from banks and financialinstitutions | ₹30.00 Cr |
| General corporate purpose | ₹7.52 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Price to Book Value |
| Expense | Amount |
|---|---|
| Fees payable to the BRLM | ₹1.55 Cr |
| Fees payable to Registrar | ₹0.09 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank (for Bids made by Retail Individual Bidders using UPI) and Bankers to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members | ₹1.60 Cr |
| Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees, other regulatory expenses | ₹1.99 Cr |
| Printing and stationery expenses | ₹1.86 Cr |
| Advertising and marketing expenses for the Offer | ₹6.61 Cr |
| Fees for the legal counsel appointed for the purpose of the Offer | ₹2.45 Cr |
| Fees for CRISIL Research appointed for the purpose of the Offer | ₹0.17 Cr |
| Fees for the Statutory Auditor appointed for the purpose of the Offer | ₹0.18 Cr |
| Miscellaneous | ₹2.11 Cr |